Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2019 1
2021 3
2023 6
2024 2
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Initial Experience of (18) F-FET PET-MR Image Fusion for Evaluation of Recurrent Primary Brain Tumors.
Dadgar H, Vafaee MS, Khorasanchi A, Moghadam PK, Nemati R, Shooli H, Jafari E, Assadi M. Dadgar H, et al. World J Nucl Med. 2023 Sep 6;22(3):183-190. doi: 10.1055/s-0043-1771282. eCollection 2023 Sep. World J Nucl Med. 2023. PMID: 37854091 Free PMC article.
This study was conducted to evaluate whether fused MRI and O-(2- (18) F-fluoroethyl)-L-tyrosine ( (18) F-FET) positron emission tomography (PET) can improve the diagnostic accuracy of the practitioners to discriminate treatment-related changes from true recurrence o …
This study was conducted to evaluate whether fused MRI and O-(2- (18) F-fluoroethyl)-L-tyrosine ( (18) F-FET) positron emissio …
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.
Thoms JAI, Yan F, Hampton HR, Davidson S, Joshi S, Saw J, Sarowar CH, Lim XY, Nunez AC, Kakadia PM, Bhuyan GS, Zou X, Nguyen M, Ghodousi ES, Koch FC, Vafaee F, Thompson IR, Karimi MM, Pickford R, Raftery MJ, Hough S, Buckland G, Bailey M, Ghodke Y, Absar N, Vaughan L, Pasalic L, Fong CY, Kenealy M, Hiwase DK, Stoddart RI, Mohammed S, Lee L, Passam FH, Larsen SR, Spring KJ, Skarratt KK, Rebeiro P, Presgrave P, Stevenson WS, Ling S, Tiley C, Fuller SJ, Roncolato F, Enjeti AK, Hoenemann D, Lemech C, Jolly CJ, Bohlander SK, Curtis DJ, Wong JWH, Unnikrishnan A, Hertzberg M, Olivier J, Polizzotto MN, Pimanda JE. Thoms JAI, et al. Nat Commun. 2025 May 13;16(1):4451. doi: 10.1038/s41467-025-59796-x. Nat Commun. 2025. PMID: 40360497 Free PMC article. Clinical Trial.
Human Group IIA Phospholipase A2-Three Decades on from Its Discovery.
Scott KF, Mann TJ, Fatima S, Sajinovic M, Razdan A, Kim RR, Cooper A, Roohullah A, Bryant KJ, Gamage KK, Harman DG, Vafaee F, Graham GG, Church WB, Russell PJ, Dong Q, de Souza P. Scott KF, et al. Molecules. 2021 Nov 30;26(23):7267. doi: 10.3390/molecules26237267. Molecules. 2021. PMID: 34885848 Free PMC article. Review.
An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.
Shooli H, Dadgar H, Wáng YJ, Vafaee MS, Kashuk SR, Nemati R, Jafari E, Nabipour I, Gholamrezanezhad A, Assadi M, Larvie M. Shooli H, et al. Quant Imaging Med Surg. 2019 Sep;9(9):1597-1610. doi: 10.21037/qims.2019.08.16. Quant Imaging Med Surg. 2019. PMID: 31667145 Free PMC article. Review.
Application of PET tracers in brain neoplasm depends on both type of the neoplasm and the research or clinical significance required to be addressed. In clinical neuro-oncology, (18)F-FDG is used mainly to differentiate tumor recurrence from radiation-induced necrosis, and …
Application of PET tracers in brain neoplasm depends on both type of the neoplasm and the research or clinical significance required to be a …
18 results